LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

ERBA Mannheim Opens New Subsidiary in Brazil

By LabMedica International staff writers
Posted on 12 Sep 2019
ERBA Mannheim has expanded its global footprint by opening a new subsidiary in Brazil. The new organization, Erba Mannheim Brazil, will be headquartered in Nova Lima, north of the nation’s capital, will sell a full range of blood and urine test automation solutions in clinical chemistry, hematology, hemostasis, immunoassay, urinalysis, diabetes, critical care and microbiology.

“This new operation significantly enhances our footprint in LATAM,” said Nikhil Vazirani, MD of Erba Mannheim. “We have an excellent team who are looking forward to helping improve workflow and quality whilst reducing cost and turnaround time of Brazilian labs.”

“We are very excited to be able to serve our customers and support our channel partners from within Brazil,” said Tarcisio Vilhena, Brazil country manager. “We have a dedicated team ready to support our customers with application and service expertise as well as sales and marketing support. From the simplest semi-automatic system to the impressive sophistication of our future NEXUS range, we are committed to help improve the lives of millions in Brazil through high quality, affordable automation.”

Erba Mannheim Brazil also showcased key products, including XL200 and XL640 clinical chemistry instruments, LAURA XL automatic urinalysis system, Elite 580 and H560 automatic hematology analyzers and the ECL760 automatic coagulation analyzer, at the 53rd Brazilian Congress of Clinical Pathology in Rio Janeiro, held September 24-27, 2019.

ERBA Mannheim


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Drug Testing Assays
Atellica DT 250 Analyzer
Hematology Consumables
Bioblood Devices

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
12 Sep 2019  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
12 Sep 2019  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
12 Sep 2019  |   Industry